Related Experiment Videos
Abstract:
The early and recent investigations in the field of retinoids and cancer are reviewed. The retinoids, including natural vitamin A compounds and their synthetic analogs, present a new class of substances exerting a prophylactic and a therapeutic effect both in certain experimental tumor models and in certain clinical conditions of preneoplastic and neoplastic lesions. Because of a particular physiological mechanism of action, the retinoids offer a new approach to the cancer problem, which is different from those of surgery, X-ray therapy, conventional chemotherapy, and immunotherapy.
Insights
Retinoids, vitamin A derivatives, show promise in preventing and treating cancer. These compounds offer a novel therapeutic avenue distinct from traditional cancer treatments.
Area of Science:
- Oncology
- Dermatology
- Molecular Biology
Background:
- Retinoids encompass natural vitamin A compounds and synthetic analogs.
- These substances have demonstrated significant biological activities.
- Their role in cellular differentiation and proliferation is well-documented.
Purpose of the Study:
- To review early and recent investigations on retinoids in cancer.
- To highlight the prophylactic and therapeutic potential of retinoids.
- To introduce retinoids as a novel approach to cancer treatment.
Main Methods:
- Literature review of preclinical and clinical studies.
- Analysis of experimental tumor models.
- Evaluation of clinical data on preneoplastic and neoplastic lesions.
Main Results:
- Retinoids exhibit prophylactic effects against certain tumors.
- Retinoids demonstrate therapeutic efficacy in preneoplastic and neoplastic conditions.
- A unique physiological mechanism of action distinguishes retinoids.
Conclusions:
- Retinoids represent a promising class of compounds for cancer prevention and treatment.
- Their distinct mechanism offers an alternative to conventional cancer therapies.
- Further research into retinoids could revolutionize cancer management.